Organigram Holdings Inc. (NASDAQ:OGI – Get Free Report) was the target of a large increase in short interest during the month of February. As of February 15th, there was short interest totalling 4,300,000 shares, an increase of 58.1% from the January 31st total of 2,720,000 shares. Based on an average daily volume of 911,500 shares, the days-to-cover ratio is presently 4.7 days. Approximately 4.8% of the shares of the company are sold short.
Organigram Price Performance
Organigram stock traded up $0.03 during trading hours on Tuesday, hitting $1.10. 1,286,974 shares of the stock traded hands, compared to its average volume of 992,157. The firm’s 50 day moving average price is $1.49 and its 200-day moving average price is $1.63. The stock has a market capitalization of $138.84 million, a price-to-earnings ratio of -2.89 and a beta of 1.00. Organigram has a 1 year low of $1.02 and a 1 year high of $2.91.
Organigram (NASDAQ:OGI – Get Free Report) last issued its earnings results on Tuesday, February 11th. The company reported ($0.05) EPS for the quarter, missing analysts’ consensus estimates of ($0.03) by ($0.02). Organigram had a negative return on equity of 8.59% and a negative net margin of 31.69%. Research analysts forecast that Organigram will post -0.19 earnings per share for the current fiscal year.
Hedge Funds Weigh In On Organigram
Organigram Company Profile
Organigram Holdings Inc, through its subsidiaries, engages in the production and sale of cannabis and cannabis-derived products in Canada. It offers medical cannabis products, including whole flower, milled flower, pre-rolls, infused pre-rolls, vapes, gummies, and concentrates for medical retailers; adult use recreational cannabis under the SHRED, Holy Mountain, Big Bag O' Buds, Monjour, Trailblazer, SHRED'ems, Edison Cannabis Co, Edison JOLTS, Tremblant, and Laurentian brands.
Read More
- Five stocks we like better than Organigram
- Why Special Dividends Can be a Delightful Surprise for Income Investors
- GitLab: Get In While It’s Down—Big Rebound Ahead
- Following Congress Stock Trades
- Tesla Stock: Finding a Bottom May Take Time
- 2 Rising CRM Platform Stocks That Can Surge Higher in 2025
- Duolingo: This Beaten-Down Stock Is About to Rally 38%
Receive News & Ratings for Organigram Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Organigram and related companies with MarketBeat.com's FREE daily email newsletter.